Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00490_DB00661_nanopub.RAOZdp4_THcv1GiBdTs5Ji9t6pKKMYFbB0eX2PfjFJg-g#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00490_DB00661 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00490_DB00661 label "DDI between Buspirone and Verapamil - Verapamil may increase the serum concentration of Buspirone. The likely occurs via Verapamil-mediated CYP3A4 inhibition resulting in decreased Buspirone metabolism. Monitor for changes in the therapeutic/adverse effects of Buspirone if Verpamil is initiated, discontinued or dose changed. [drugbank_resource:DB00490_DB00661]" assertion.
- drugbank_resource:DB00490_DB00661 identifier "drugbank_resource:DB00490_DB00661" assertion.
- drugbank_resource:DB00490_DB00661 title "DDI between Buspirone and Verapamil - Verapamil may increase the serum concentration of Buspirone. The likely occurs via Verapamil-mediated CYP3A4 inhibition resulting in decreased Buspirone metabolism. Monitor for changes in the therapeutic/adverse effects of Buspirone if Verpamil is initiated, discontinued or dose changed." assertion.
- drugbank:DB00661 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00490_DB00661 assertion.
- drugbank:DB00490 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00490_DB00661 assertion.